Inmune Bio Balance Sheet (2017-2025) | INMB

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter)	45.34M	39.52M	84.47M	74.81M	66.73M	59.72M	57.41M	52.15M	51.00M	47.83M	41.81M	35.85M	26.00M	31.07M	33.55M	20.92M	19.34M	33.37M	27.73M	24.75M
Cash & Current Investments (Quarter)	45.34M	39.52M	84.47M	74.81M	66.73M	59.72M	57.41M	52.15M	51.00M	47.83M	41.81M	35.85M	26.00M	31.07M	33.55M	20.92M	19.34M	33.37M	27.73M	24.75M
Receivables - Net (Quarter)	0.10M	0.10M	0.10M	0.10M								1.91M		3.14M	1.11M	1.18M	1.28M	2.00M	1.70M	4.28M
Receivables - Other (Quarter)				0.30M	0.20M	0.20M	0.10M	0.36M				0.54M	0.56M	0.59M	0.55M	0.23M	0.13M	0.55M	0.76M	0.26M
Receivables (Quarter)	0.10M	0.10M	0.10M	0.40M	0.20M	0.20M	0.10M					2.44M		3.73M	1.65M	1.41M	1.42M	2.55M	2.46M	4.54M
Prepaid Assets (Quarter)	1.51M	1.40M	1.30M	2.28M	4.67M	4.22M	4.60M	4.03M	3.63M	0.03M	1.53M	1.51M	1.11M	1.01M	0.86M	0.33M	0.21M	0.51M	0.47M	0.59M
Current Assets (Quarter)	49.21M	44.05M	90.93M	82.61M	77.06M	70.55M	66.66M	64.67M	56.88M	52.61M	45.61M	39.94M	29.82M	35.49M	35.85M	22.66M	20.96M	36.03M	30.67M	29.89M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)																		0.71M	0.88M	0.95M
Intangibles (Quarter)	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M
Goodwill & Intangibles (Quarter)	16.51M	16.51M	16.51M	0.10	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M	16.51M
Long-Term Deferred Tax (Quarter)				6.79M				13.70M				19.60M		0.59M	0.55M	25.70M
Other Non-Current Assets (Quarter)			0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.13M	0.13M	0.13M	0.11M	0.08M	0.08M	0.08M	0.05M	0.57M	0.75M	0.59M
Non-Current Assets (Quarter)	16.66M	16.65M	16.74M	17.34M	17.29M	17.26M	17.14M	17.12M	17.10M	17.11M	17.09M	17.06M	17.01M	16.96M	16.93M	16.90M	16.84M	1.65M	2.69M	2.20M
Assets (Quarter)	65.87M	60.70M	107.67M	99.94M	94.35M	87.81M	83.80M	81.80M	73.98M	69.72M	62.70M	57.00M	46.83M	52.45M	52.78M	39.56M	37.80M	37.68M	33.36M	32.35M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	1.57M	2.36M	4.22M	0.08M	0.01M	1.69M	0.01M	5.21M	2.08M	2.38M	3.67M	7.90M	9.29M	9.28M	10.59M	6.54M	0.03M	0.03M	6.88M	7.77M
Payables (Quarter)	1.57M	2.36M	4.22M	0.08M	0.01M	1.69M	0.01M	5.21M	2.08M	2.38M	3.67M	7.90M	9.29M	9.28M	10.59M	6.54M	0.03M	0.03M	6.88M	7.77M
Accumulated Expenses (Quarter)								0.01M	0.01M	0.01M	0.08M	0.04M	0.06M	0.14M
Other Accumulated Expenses (Quarter)	0.59M	0.58M	0.54M	0.47M	0.58M	0.48M	0.78M	0.62M	0.59M	0.56M	0.50M	0.49M	0.52M	0.52M	0.55M	0.52M	0.48M	0.51M
Short term Debt (Quarter)							2.50M	5.00M	7.50M	10.00M	10.00M	9.92M	7.46M	4.98M	2.49M
Current Leases (Quarter)	0.02M	0.04M	0.04M	0.14M	0.08M	0.11M	0.14M	0.09M	0.11M	0.10M	0.11M	0.12M	0.12M	0.13M	0.14M	0.14M	0.15M	0.22M	0.46M	0.62M
Total Current Liabilities (Quarter)	2.20M	2.99M	4.81M	4.36M	3.23M	2.29M	6.89M	10.92M	10.28M	13.05M	14.36M	18.46M	17.45M	15.05M	13.82M	7.22M	7.93M	8.59M	7.36M	8.42M
Non-Current Liabilities
Non-Current Debt (Quarter)		14.35M	14.40M	14.46M	14.51M	14.57M	12.13M	9.70M	7.26M	4.82M	2.38M		7.50M	5.00M	2.50M
Non-Current Deffered Revenue (Quarter)
Preferred Stock Liabilities (Quarter)											0.80M	0.80M	0.80M	0.80M
Non-Current Deferred Tax Liability (Quarter)				0.26M
Operating Leases (Quarter)	0.12M	0.11M	0.10M	0.28M	0.77M	0.65M	0.75M	0.53M	0.50M	0.46M	0.54M	0.40M	0.36M	0.32M	0.28M	0.24M	0.20M	0.45M	0.62M	0.41M
Other Non-Current Liabilities (Quarter)		0.16M	0.24M					0.55M			0.80M
Total Non-Current Liabilities (Quarter)		17.31M	19.17M	19.72M	18.71M			21.14M			17.16M
Total Liabilities (Quarter)	2.31M	17.47M	19.42M	19.72M	18.71M	17.88M	20.09M	21.69M	18.68M	19.07M	17.97M	18.86M	17.81M	15.37M	14.11M	7.46M	8.13M	8.82M	7.98M	8.83M
Shareholder's Equity
Total Debt (Quarter)		14.35M	14.40M	14.46M	14.51M	14.57M	14.63M	14.70M	14.76M	14.82M	12.38M	9.92M	14.96M	9.98M	4.99M
Common Equity (Quarter)	63.56M	43.23M	88.25M	80.22M	75.64M	69.93M	63.71M	60.10M	55.30M	50.65M	43.93M	37.34M	28.22M	36.28M	38.67M	32.10M	29.67M	28.87M	25.38M	23.52M
Shareholder's Equity (Quarter)	63.56M	43.23M	88.25M	80.22M	75.64M	69.93M	63.71M	60.10M	55.30M	50.65M	43.93M	37.34M	28.22M	36.28M	38.67M	32.10M	29.67M	28.87M	25.38M	23.52M
Liabilities and Shareholders Equity (Quarter)	65.87M	60.70M	107.67M	99.94M	94.35M	87.81M	83.80M	81.80M	73.98M	69.72M	62.70M	57.00M	46.83M	52.45M	52.78M	39.56M	37.80M	37.68M	33.36M	32.35M
Retained Earnings (Quarter)	-37.93M	-0.05M	-0.12M	0.00M	0.06M	-0.70M	-1.14M	-0.70M	-0.71M	-0.71M	-0.73M	-0.80M	-0.67M	-0.71M	-153.89M	-0.57M	-0.61M	-197.30M	-0.76M	-209.04M
Preferred Shares (Quarter)

Research Tools

Inmune Bio Balance Sheet (2017-2025) | INMB

Create an account

Sign In

Reset Password